224AE3

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name224AE3
Drug Alias Nameanti-Factor IXa antibody (Baxter)224AE3
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCoagulation factor X modulatorsCoagulation factor IX inhibitors
TargetsCoagulation factor IXCoagulation factor X
Therapy Area/IndicationsHemophilia AThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBaxter International Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBaxter International Inc
Active IndicationsN/A
Inactive IndicationsHemophilia AThrombosis

Other Information

ATC CodeN/A
Related LinksN/A